Lineage's epinephrine auto-injector is the only generically priced epinephrine auto-injector currently available. This authorized generic epinephrine injection, USP auto-injector, is being ...

JERUSALEM & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr®1 (epinephrine ...

Add Yahoo as a preferred source to see more of our stories on Google. Consumer Reports has no financial relationship with advertisers on this site. Consumer Reports has no financial relationship with ...

Mylan’s life-saving epinephrine auto-injector EpiPen now has a generic rival, the Food and Drug Administration (FDA) triumphantly announced. Teva Pharmaceuticals USA now has FDA approval to market a ...

CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...

Please provide your email address to receive an email when new articles are posted on . The costs of epinephrine autoinjectors have decreased since generic options arrived in 2016, but these costs ...

The FDA cleared the first generic version of EpiPen and EpiPen Jr, an epinephrine auto-injector for severe allergic reactions, 2 years after generic drugmaker Teva Pharmaceuticals was first turned ...

NASHVILLE, Tenn. (WKRN) – – The U.S. Food and Drug Administration approved the first generic version of the EpiPen. Teva Pharmaceuticals USA gained approval to market its generic epinephrine ...

DUBLIN--(BUSINESS WIRE)--The "Epinephrine Auto-Injector Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The Global Epinephrine Auto-Injector ...

EpiPen will face competition in a generic version of the auto-injector marketed by Teva Pharmaceuticals and approved by the U.S. Food and Drug Administration on Thursday. The FDA previously approved ...

EWING, N.J., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that the U.S. Food and Drug Administration (FDA ...

Dublin, April 30, 2020 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injector Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The Global ...